Last reviewed · How we verify
NCT05032027: probiotics
Oral Probiotics on Radiation Enteritis Stage Ⅱ Induced by Pelvic Concurrent Chemoradiotherapy
NA trial testing probiotics in Pelvic Cancer, Enteritis, Probiotics,Chemoradiotherapy in 40 participants. Status unknown.
27 December 2022
Quick facts
| Lead sponsor | Jiangxi Provincial Cancer Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | prevention |
| Enrollment | 40 |
| Start date | 27 August 2021 |
| Primary completion | 27 December 2022 |
| Estimated completion | 1 December 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- probiotics — full drug profile →
Conditions studied
- Pelvic Cancer, Enteritis, Probiotics,Chemoradiotherapy — all drugs for Pelvic Cancer, Enteritis, Probiotics,Chemoradiotherapy →
Sponsor
Jiangxi Provincial Cancer Hospital
Who can join
Adults 18 to 65, any sex, with Pelvic Cancer, Enteritis, Probiotics,Chemoradiotherapy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Effect of Probiotics on Raditon Enteritis in Pelvic Tumor Patients Receiving Radiotherapy.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications.
Zhao LY, Mei JX, Yu G, Lei L, et al · · 2023 · cited 211× · PMID 37179402 · DOI 10.1038/s41392-023-01406-7 -
Microbiota in cancer: current understandings and future perspectives.
Yao Y, Zhu Y, Chen K, Chen J, et al · · 2026 · cited 2× · PMID 41629271 · DOI 10.1038/s41392-025-02335-3 -
Ionizing radiation: molecular mechanisms, biological effects, and therapeutic targets.
Wei W, Ren Y, Lan J, Yi J, et al · · 2026 · PMID 41507636 · DOI 10.1186/s43556-025-00358-4
Verify or expand the search:
- PubMed search for NCT05032027
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of probiotics
Trials testing the same drug.
- NCT07333313 — Study of Oral Uremic Toxin Absorbent/Probiotics to Modulate Systemic Inflammation and Retard the Progression of Chronic · NA · recruiting
- NCT07182942 — The Effect and Mechanism of Xiqing Regulating Intestinal Homeostasis on Drug Efficacy of Chronic Kidney Disease · Phase 4 · recruiting
- NCT06554314 — Effect of Probiotics on Regulating Gut Health and Blood Lipid in Adults · NA · recruiting
- NCT06381479 — Exploring the Effects of Probiotics on Workplace Related Stress Symptoms · NA · completed
- NCT06118294 — Efficacy of Probiotics for Parkinson Disease (PD) · NA · withdrawn
Other Jiangxi Provincial Cancer Hospital trials
Trials by the same sponsor.
- NCT07314255 — The Role of Trop2 in Radioactive Iodine-131 Therapy Sensitivity in Papillary Thyroid Carcinoma · active not recruiting
- NCT07277764 — Induction High-Low Dose Radiotherapy Plus Anti-PD-1 Followed by Definitive Radiotherapy in Recurrent Nasopharyngeal Carc · Phase 2 · recruiting
- NCT06752239 — Prophylactic Radiotherapy Optimization for Enhanced Thyroid Function Protection in NPC · Phase 3 · recruiting
- NCT07085988 — Effect of Nutritional Management on Patients With Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma · Phase 2 · recruiting
- NCT06770699 — Tertiary Lymphoid Structures in Nasopharyngeal Carcinoma · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05032027 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jiangxi Provincial Cancer Hospital
- Last refreshed: 2 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05032027.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing